Motilent secures additional funding for bowel care technology

Motilent secures additional funding for bowel care technology

UK start-up Motilent has been awarded additional funding from the National Institute for Health and Care Research (NHIR), which will be used to develop and roll out technology to provide data-led insights into inflammatory bowel disease and Crohnā€™s disease.

The company specialises in the assessment of digestive diseases using AI medical image analysis. It received an initial Ā£685k investment from the NIHR which was used to accelerate the development of GiQuant, a tool which measures and tracks movement of the intestine.

An additional Ā£562k of NIHR funding will now be used to support the rollout of GiQuant to NHS hospitals including University College London Hospital, Nottingham University Hospital and Frimley Park Hospital.

Alex Menys, CEO, Motilent said: ā€œOne of the first questions we are asked is ā€˜who else is using GIQuant?ā€™ and through this grant we have an opportunity to really drive the tech into a lot of different types of hospitals and give the clinical community the time (and resource) to see how GIQuant can fit their workflows. This of course builds on regulatory clearance and a large number of published papers, but there is no substitution for hands-on use.ā€

GiQuant is used alongside MRI scans to provide insights into disease progression and treatment response. The data is collected non-invasively and can be used by clinicians to identify ineffective treatments faster, and speed up the treatment journey for those with Crohnā€™s disease.

Stuart Taylor, professor of medical imaging at UCL, said: ā€œThere is a real clinical need to improve the diagnosis and monitoring of gastrointestinal diseases. GIQuant holds considerable promise as a non-invasive tool to measure the inflammatory burden in Crohnā€™s disease and help clinicians better manage patients. This study will allow us to deploy GIQuant within real world clinical practice and evaluate its impact.ā€

The technology is already used within the NHS ā€“ including at Great Ormond Street Hospital.

As well as funding the wider roll out of the technology in the NHS it will also support a retrospective study on historic MRI scans to help drive change in the clinical management of Crohnā€™s disease.

The funding was awarded through the NIHRā€™s Invention for Innovation (i4i) programme, which is supporting the development of medical technologies to advance treatment for gut issues.

Raffaella Roncone, head of innovation and enterprises for NIHR’s i4i programme, added: ā€œMotilent’s innovative work to find better ways to see inside the gut and monitor how treatment is working really has the potential to improve patients’ lives, and make the healthcare system more effective.ā€

Back in 2019 Motilent were part of the fourth cohort of health tech companies to join the DigitalHealth.London’s accelerator programme.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Creating a home for healthcare innovation in Leeds

Creating a home for healthcare innovation in Leeds

A physical space for innovation at Leeds Teaching Hospitals NHS Trust has supported colloboration and new ideas, writes Richard Evans.
Government launches AI breast cancer trial

Government launches AI breast cancer trial

The government has announced the launch of a trial that will test how AI tools can be used to detect cases of breast cancer earlier.
Study to explore digital weight management support for obesity

Study to explore digital weight management support for obesity

A study at the University of Warwick is looking at how an app and remote consultations could help the NHS support people living with obesity.